PDF) Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients | Alberto Roghi and Angela Milazzo - Academia.edu
PDF) Non-transferrin-bound iron negatively correlates with red cell glutathione in beta-thalassemia intermedia.
Curriculum Vitae Maria Domenica Cappellini INFORMAZIONI PERSONALI MARIA DOMENICA CAPPELLINI ESPERIENZA PROFESSIONALE POSIZIONE
A reappraisal of Gaucher disease—diagnosis and disease management algorithms - Mistry - 2011 - American Journal of Hematology - Wiley Online Library
TIF & EHA Host Webinar on Thalassemia/SCD & COVID-19 - The Cooley's Anemia Foundation
Maria Domenica Cappellini - Osservatorio Terapie Avanzate
PDF) Acute Intermittent Porphyria: Heterogeneity of Mutations in the Hydroxymethylbilane Synthase Gene in Italy | Franco Martinez - Academia.edu
Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome - Papo - 1999 - British Journal of Haematology - Wiley Online Library
Update on the use of deferasirox in the management of iron overload
Curriculum Vitae Maria Domenica Cappellini INFORMAZIONI PERSONALI MARIA DOMENICA CAPPELLINI ESPERIENZA PROFESSIONALE POSIZIONE
PDF) Quality of life in patients with beta‐thalassemia: a prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand | Abderrahmane Laadem - Academia.edu
PDF) Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload | Gian Forni - Academia.edu
PDF) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with -thalassemia | Thomas D. Coates - Academia.edu
Curriculum Vitae Maria Domenica Cappellini INFORMAZIONI PERSONALI MARIA DOMENICA CAPPELLINI ESPERIENZA PROFESSIONALE POSIZIONE
Maria Domenica Cappellini- Corriere.it
Maria Domenica Cappellini | Videos & Research | VJHemOnc
β-talassemia
Sickle cell disease: where we are now | VJHemOnc
Hyperferritinemia and diagnosis of type 1 Gaucher disease - Marchi - 2020 - American Journal of Hematology - Wiley Online Library
EHA 2022: Effects of Luspatercept on Need for Red Blood Cell Transfusions are Sustained in Patients with β-Thalassemia | PracticeUpdate
An Instrument Assessing Satisfaction with Iron Chelation Therapy: Psychometric Testing From an Open-Label Clinical Trial
CRISPR's “magnificent moment” in the clinic
Oxidative stress modulates heme synthesis and induces peroxiredoxin-2 as a novel cytoprotective response in β-thalassemic eryth
SITE | Società Italiana Talassemie ed Emoglobinopatie
Maria Domenica Cappellini - insalutenews.it
